viewFrontier IP Group PLC

Frontier IP spins out third Portuguese firm Insignals Neurotech

Frontier IP Group Plc (LON:FIPP) has unveiled its third Portuguese spin out, Insignals. Frontier IP CEO Neil Crabb tells Proactive London how wrist rigidity is used by doctors to decide the optimum position for an implant during surgery, but currently, this is done by two trained surgeons making a judgement by manually manipulating the wrist, meaning the procedure can be biased by the physicians' experience and perception.
The IP commercialisation firm said it would hold a 33% stake in Insignals, which is a spin-out from the work of Professor João Paulo Cunha at the University of Porto and is developing wearable wireless devices to precisely measure wrist rigidity to help surgeons place brain implants more accurately during surgery on patients with Parkinson’s, epilepsy, and other neural conditions.

Quick facts: Frontier IP Group PLC

Price: 54.5 GBX

Market: AIM
Market Cap: £27.62 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...



Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials...

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals. Crabb says the idea is to develop an animal inoculation that would prevent the spread of...

1 week, 5 days ago

2 min read